drugset / Trial / NCT00595790

Rapid Immunization Study of the Japanese Encephalitis Vaccine IC51

NCT00595790

Phase 3 Completed 374 enrolled Valneva Austria GmbH
RandomizedParallel-groupSingle-blindPrevention

Summary

The study investigates a rapid immunization regime of the Japanese Encephalitis vaccine IC51 (JE-PIV) in healthy subjects aged \> or = 18 years

Timeline

Start
2005-09
Primary completion
2006-02
Completion
2007-11

Drugs

EvaluationDrugModalityDoseRoute
Comparator IC51 Vaccine 6 ug
Comparator IC51 Vaccine 12 ug

Indications